EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.99.B1 | medicine | excision of RCE1 from skin carcinoma cell line retards the growth of cells significantly, and this effect was exaggerated by co-treatment with farnesyl-transferase inhibitor | Mus musculus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
3.4.99.B1 | additional information | RCE1 deficient mice generated, loss of the enzyme results in late embryonic lethality | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.99.B1 | beta-(2-naphthyl)-Ala-CH2Cl | affinity labeling agent of the enzyme | Bos taurus | |
3.4.99.B1 | additional information | not inhibited by chyostatin, DTT, E-64, 1,10-phenanthroline and PMSF, Tos-Lys-CH2Cl | Bos taurus | |
3.4.99.B1 | N-Boc-S-farnesyl-L-cys-CH2Cl | - |
Bos taurus | |
3.4.99.B1 | N-Boc-S-farnesyl-L-cysteine aldehyde | potent competetive inhibitor | Bos taurus | |
3.4.99.B1 | p-chloromercuribenzoate | inactivates the partially purified enzyme, with 0.005 mM substantial inhibition | Bos taurus | |
3.4.99.B1 | pseudo peptide R (CH2-NH) | - |
Bos taurus | |
3.4.99.B1 | Tos-Phe-CH2Cl | affinity labeling agent of the enzyme | Bos taurus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.99.B1 | 0.0057 | - |
N-acetyl-S-farnesyl-L-cysteinyl-L-valyl-L-isoleucyl-L-serine | - |
Bos taurus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.99.B1 | membrane | - |
Homo sapiens | 16020 | - |
3.4.99.B1 | microsome | - |
Bos taurus | - |
- |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.99.B1 | Bos taurus | - |
- |
- |
3.4.99.B1 | Homo sapiens | - |
- |
- |
3.4.99.B1 | Mus musculus | - |
- |
- |
3.4.99.B1 | Saccharomyces cerevisiae | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.99.B1 | carcinoma cell line | from skin | Mus musculus | - |
3.4.99.B1 | liver | - |
Bos taurus | - |
3.4.99.B1 | MEF cell | - |
Mus musculus | - |
3.4.99.B1 | additional information | Sf9 cell | Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.99.B1 | 0.00000251 | - |
with N-acetyl-S-farnesyl-Cys+Val-Ile-Ser as substrate | Bos taurus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.99.B1 | a-factor-CaaX + H2O | CaaX proteolysis of all three forms of Ras and other CaaX proteins is absent in RCE1 deficient mice, RCE1 is required for correct localization of these proteins | Mus musculus | a-factor-C + aaX | - |
? | |
3.4.99.B1 | N-acetyl-S-farnesyl-Cys-Val-Ile-Ser + H2O | - |
Bos taurus | N-acetyl-S-farnesyl-Cys + Val-Ile-Ser | - |
? | |
3.4.99.B1 | N-Boc-S-farnesyl-L-Cys-Val-Ile-Met + H2O | - |
Bos taurus | N-Boc-S-farnesyl-L-Cys + Val-Ile-Met | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.99.B1 | isoprenylated protein peptidase | - |
Mus musculus |
3.4.99.B1 | isoprenylated protein peptidase | - |
Homo sapiens |
3.4.99.B1 | isoprenylated protein peptidase | - |
Saccharomyces cerevisiae |
3.4.99.B1 | isoprenylated protein peptidase | - |
Bos taurus |
3.4.99.B1 | RCE1 | - |
Mus musculus |
3.4.99.B1 | RCE1 | - |
Homo sapiens |
3.4.99.B1 | RCE1 | - |
Saccharomyces cerevisiae |
3.4.99.B1 | RCE1 | - |
Bos taurus |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.99.B1 | 7 | - |
- |
Bos taurus |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.99.B1 | 0.000085 | - |
pseudo peptide R (CH2-NH) | - |
Bos taurus | |
3.4.99.B1 | 0.002 | - |
N-Boc-S-farnesyl-L-cysteine aldehyde | - |
Bos taurus | |
3.4.99.B1 | 0.03 | - |
N-Boc-S-farnesyl-L-cys-CH2Cl | - |
Bos taurus |